Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 14, 2016
Drugs and Therapeutics (D & T) Committee
Drugs Under Review for:
September 14, 2016
Drug Name | Review Type | Class | Manufacturer |
Viekira HR | New Drug Initial Review | Hepatitis C | AbbVie |
Ocaliva | New Drug Initial Review | Primary Biliary Cholangitis | Intercept Pharmaceuticals |
Briviact | New Drug Initial Review | Anticonvulsant | UCB, Inc. |
Epclusa | New Drug Initial Review | Hepatitis C | Gilead Sciences |
Xtampza ER | New Drug Initial Review | Extended Release Opioid | Collegium Pharmaceutical |
Spinosad | New Drug Initial Review | Lice Treatment | ParaPro |
Adzenys XR-ODT | New Drug Initial Review | Stimulant | Neos Therapeutics |
Orenitram | New Drug Appeal | Pulmonary Arterial Hypertension | United Therapeutics |